Orphan drugs and the NHS: consider whom drug regulation is designed to protect.
Marshall
Tom
T
D003362:Cost-Benefit Analysis; D006801:Humans; D009965:Orphan Drug Production / Q000191:economics*; D035583:Rare Diseases / Q000188:drug therapy*; D013222:State Medicine